ALLMedicine™ Stents Center

Oct 3rd, 2022 - Conventional stents "cage" the coronary arteries, impairing vascular function and physiology. The DynamX Bioadaptor is a cobalt‑chromium platform with uncaging elements, designed to improve arterial pulsatility, vasomotion, compliance, and positiv...

Oct 3rd, 2022 - To analyze the efficacy and safety of sirolimus-eluting stents (SES) in the treatment of below-the-knee (BTK) arterial disease. An electronic literature search was conducted from inception to 24 July 2021. Retrospective, prospective or randomized ...

Oct 2nd, 2022 - Due to demographic aging, the prevalence of coronary artery disease (CAD) is expected to increase in the future, resulting in a growing demand for stent and bypass interventions. This study aims to investigate the mortality risk of patients follow...

Sep 30th, 2022 - There is a scarcity of studies comparing percutaneous coronary intervention (PCI) using new-generation drug-eluting stents (DES) with coronary artery bypass grafting (CABG) in patients with multi-vessel coronary artery disease. The CREDO-Kyoto PCI...

Sep 29th, 2022 - We aimed to assess the clinical performance and risk factors for patency loss within 2 years following the use of polymer-coated paclitaxel-eluting stents (PC-PESs) and drug-coated balloons (DCBs) in patients with lower extremity artery disease. M...

Jul 28th, 2021 - Lumen-apposing metal stents (LAMSs) are a novel class of devices that have expanded the spectrum of endoscopic GI interventions. LAMSs with their dumbbell configuration, short saddle length, and large inner luminal diameter provide favorable stent...

Nov 11th, 2020 - This American Society for Gastrointestinal Endoscopy guideline provides evidence-based recommendations for the endoscopic management of gastric outlet obstruction (GOO). We applied the Grading of Recommendations, Assessment, Development and Evalua...

Nov 4th, 2021 - Updated November 4, 2021, 8:40 PM // Editor's Note: This story has been updated with additional commentary from various experts. Coronary stenting guided by fractional flow reserve (FFR) readings, considered to reflect the targeted lesion's functi...

Jun 4th, 2021 - It was back to the drawing board for bioresorbable vascular scaffolds (BVS), to some degree, after the initially promising ABSORB series of trials dampened any enthusiasm for the coronary stent-like devices designed to dissolve over time. A second...

Dec 8th, 2020 - NEW YORK (Reuters Health) - Covered and uncovered self-expandable metal stents (SEMS) for malignant gastric outlet obstruction show only minor differences, suggests a randomized trial in Japan. U.S. experts agree, noting that covered stents are no...

Nov 24th, 2020 - A novel stent designed to target early wound healing met the primary noninferiority end point at 1 year in the PIONEER III trial, but differentiating itself from current high-performing durable-polymer drug-eluting stents (DES) will require more. ...

Oct 21st, 2020 - The sirolimus-eluting Slender IDS coronary stent (Svelt Medical Systems), exquisitely skinny to simplify crossing lesions without predilatation, came up short in a randomized noninferiority trial against familiar Xience (Abbott Vascular) and Promu...